TY - JOUR
T1 - Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria
AU - Esquer Garrigos, Zerelda
AU - George, Merit P.
AU - Vijayvargiya, Prakhar
AU - Tan, Eugene M.
AU - Farid, Saira
AU - Abu Saleh, Omar M.
AU - Friedman, Paul A.
AU - Steckelberg, James M.
AU - DeSimone, Daniel C.
AU - Wilson, Walter R.
AU - Baddour, Larry M.
AU - Sohail, M. Rizwan
N1 - Funding Information:
Potential Competing Interests: Dr Friedman reports receiving honoraria/consultant fees from Medtronic, Guidant, and AstraZeneca; research grants from Medtronic, AstraZeneca via Beth Israel, Guidant, St Jude Children's Research Hospital, and Bard; and intellectual property rights with Bard EP, Hewlett-Packard, and Medical Positioning Inc. Dr Baddour reports receiving royalty payments (authorship) from UpToDate Inc and editor-in-chief payments from Massachusetts Medical Society (Journal Watch Infectious Diseases). Dr Sohail reports receiving funds from Medtronic for previous research unrelated to this study and honoraria/consulting fees from Medtronic, Spectranetics, and Boston Scientific. The other authors report no competing interests. Potential Competing Interests: Dr Friedman reports receiving honoraria/consultant fees from Medtronic, Guidant, and AstraZeneca; research grants from Medtronic, AstraZeneca via Beth Israel, Guidant, St Jude Children's Research Hospital, and Bard; and intellectual property rights with Bard EP, Hewlett-Packard, and Medical Positioning Inc. Dr Baddour reports receiving royalty payments (authorship) from UpToDate Inc and editor-in-chief payments from Massachusetts Medical Society (Journal Watch Infectious Diseases). Dr Sohail reports receiving funds from Medtronic for previous research unrelated to this study and honoraria/consulting fees from Medtronic, Spectranetics, and Boston Scientific. The other authors report no competing interests.
Funding Information:
Potential Competing Interests: Dr Friedman reports receiving honoraria/consultant fees from Medtronic, Guidant, and AstraZeneca; research grants from Medtronic , AstraZeneca via Beth Israel, Guidant, St Jude Children's Research Hospital, and Bard; and intellectual property rights with Bard EP, Hewlett-Packard, and Medical Positioning Inc. Dr Baddour reports receiving royalty payments (authorship) from UpToDate Inc and editor-in-chief payments from Massachusetts Medical Society (Journal Watch Infectious Diseases). Dr Sohail reports receiving funds from Medtronic for previous research unrelated to this study and honoraria/consulting fees from Medtronic, Spectranetics, and Boston Scientific. The other authors report no competing interests.
Publisher Copyright:
© 2018 Mayo Foundation for Medical Education and Research
PY - 2019/7
Y1 - 2019/7
N2 - Objective: To describe and compare the clinical presentation, management, and outcomes of cardiovascular implantable electronic device (CIED) infections due to gram-negative bacteria (GNB) and CIED infections due to gram-positive bacteria (GPB). Patients and Methods: We retrospectively reviewed all CIED infection cases at Mayo Clinic from January 1, 1992, through December 31, 2015. Cases were classified based on positive microbiology data from extracted devices or blood cultures. Results: Of the 623 CIED infections during the study period, 31 (5.0%) were caused by GNB and 323 (51.8%) by GPB. Patients in the GNB group were more likely to present with local inflammatory findings at the pocket site (90.3% vs 72.4%; P=.03). All patients with bacteremia due to GNB had concomitant pocket infection compared with those with GPB (100% vs 33.9%; P=.002). After extraction, 41.9% of patients in the GNB group were managed with oral antibiotics vs 2.4% in the GPB group (P<.001). There were no statistically significant differences in infection relapse/recurrence or 1-year survival rates between the 2 groups. Conclusion: Compared with CIED infections caused by GPB, those due to GNB are more likely to present with pocket infection. Device-related GNB bacteremia almost always originates from the generator pocket. After extraction, oral antibiotic drug therapy may be a reasonable option in select cases of pocket infections due to GNB. No difference in outcomes was observed between the 2 groups.
AB - Objective: To describe and compare the clinical presentation, management, and outcomes of cardiovascular implantable electronic device (CIED) infections due to gram-negative bacteria (GNB) and CIED infections due to gram-positive bacteria (GPB). Patients and Methods: We retrospectively reviewed all CIED infection cases at Mayo Clinic from January 1, 1992, through December 31, 2015. Cases were classified based on positive microbiology data from extracted devices or blood cultures. Results: Of the 623 CIED infections during the study period, 31 (5.0%) were caused by GNB and 323 (51.8%) by GPB. Patients in the GNB group were more likely to present with local inflammatory findings at the pocket site (90.3% vs 72.4%; P=.03). All patients with bacteremia due to GNB had concomitant pocket infection compared with those with GPB (100% vs 33.9%; P=.002). After extraction, 41.9% of patients in the GNB group were managed with oral antibiotics vs 2.4% in the GPB group (P<.001). There were no statistically significant differences in infection relapse/recurrence or 1-year survival rates between the 2 groups. Conclusion: Compared with CIED infections caused by GPB, those due to GNB are more likely to present with pocket infection. Device-related GNB bacteremia almost always originates from the generator pocket. After extraction, oral antibiotic drug therapy may be a reasonable option in select cases of pocket infections due to GNB. No difference in outcomes was observed between the 2 groups.
UR - http://www.scopus.com/inward/record.url?scp=85062893845&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062893845&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2018.11.029
DO - 10.1016/j.mayocp.2018.11.029
M3 - Article
C2 - 30894248
AN - SCOPUS:85062893845
SN - 0025-6196
VL - 94
SP - 1268
EP - 1277
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 7
ER -